Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 73Observational 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Carcinoma, Transitional Cell 2Urothelial Cancer 1Urinary Bladder Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Blood Specimen Collection 131Surveys and Questionnaires 130Specimen Handling 57Observation 55Radiotherapy 44Interviews as Topic 34Surgical Procedures, Operative 32Drug Therapy 31Biopsy 28Data Collection 26Magnetic Resonance Spectroscopy 25Nivolumab 20Watchful Waiting 20Immune Checkpoint Inhibitors 18Immunotherapy 17Magnetic Resonance Imaging 17Therapeutics 17Standard of Care 16trastuzumab deruxtecan 14Liquid Biopsy 13Tomography, X-Ray Computed 13palbociclib 13Hematologic Tests 12Restraint, Physical 12Focus Groups 11Genetic Testing 11Bevacizumab 10Positron Emission Tomography Computed Tomography 10darolutamide 10enzalutamide 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × avelumab × 1 year × Clear all
NCT06412848 2026-05-28

JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Active not recruiting
360 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT04822350 2026-04-02

AVENANCE

Pfizer

Completed
596 enrolled 43 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05366725 2025-12-02

A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Completed
106 enrolled 36 charts
Genitourinary

Urothelial Cancer

NCT05287464 2025-11-26

International Multicentric Study ARON-1

Hospital of Macerata

Recruiting
1,220 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡